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Apoptosis Within Spontaneously Accepted Mouse Liver 
Allografts 
Evidence for Deletion of Cytotoxic T Cells and Implications for Tolerance 
. Induction 1 
Shiguang Qian/*+ Una Lu, *+ Fumin Fu, *+ Youping Li, *+ Wei Li, *+ Thomas E. Starzl, *+ 
John J. Fung,*+ and Angus W. Thomson*+* 
MHC-mismatched liver grafts are accepted spontaneously between many mouse strains. The underlying mechanism(s) is un· 
clear. In the 810 (H2b ) to C3H (H2k) strain combination used in this study, donor T cells within the liver were rapidly replaced 
within 2 to 4 days of transplantation with those of the recipient. Freshly isolated liver graft.infiltrating cells harvested on days 
4 and 7 exhibited strong cn responses against donor alloantigens. cn activity was reduced substantially, however, by day 14, 
although levels of cn precursors in the spleen and liver remained high. Examination of the liver allografts by in situ terminal 
deoxynucleotidyltransferase.catalyzed dUTP-digoxigenin nick end labeling on days 4,7, and 14 after transplantation revealed 
prominent apoptotic cells dispersed throughout the non parenchymal cell population. When acute liver allograft rejection was 
induced by administration of IL·2 from days 0 to 4 post.transplant (median survival time, 5 days), apoptotic activity (day 4) was 
reduced substantially, whereas cn activity was enhanced. Nonparenchymal cells isolated from allografts of untrlodified reo 
cipients 4, 7, and 14 days after transplantation exhibited significantly higher DNA fragmentation after 18·h culture than cells 
from liver isografts. Moreover, the level was 4 to 5 times higher than that of cells from IL·2·treated mice (on day 4). These 
observations suggest that T cell deletion, not regulation, may be responsible for spontaneous liver allograft acceptance. The 
molecular recognition events that cause apoptosis of infiltrating T cells and why this occurs within liver grafts, but not heart or 
skin grafts, remain to be elucidated. The Journal of Immunology, 1997, 158: 4654-4661. 
L ivers transplanted between members of MHC-disparate mouse strains survive indefinitely without a requirement 
for immunosuppressive therapy. For example. in the 
C57BUIO (BIO; H2b ) to C3H (H2k) strain combination. ortho-
topic liver grafts are accepted permanently (median survival time 
(MST).' > 100 days). while skin or heart grafts are rejected acutely 
(MST. 10 days) ( I ). Common to these different types of transplant 
is a marked T lymphocyte infiltrate that results. except in the case 
of liver. in graft destruction (2). Acceptance of the liver confers 
donor-specific unresponsiveness in vivo. e.g .• to a challenge skin 
graft (I. 3). Paradoxicaliy. however. vigorous MLR and CTL re-
sponses to donor alioantigens are generated in vitro by graft non-
parenchymal cells (NPC) and spleen cells of Ii ver allograft recip-
ients. This phenomenon. described as split tolerance (2). is also 
observed after rat liver transplantation (4) and occurs in a number 
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of other experimental models of alloreactivity (5-7). The persis-
tence of ex vivo responsiveness. including the capacity to generate 
donor-specific CTL from the spleen. indicates that clonal deletion 
of CTL precursors (CTLp) does not occur. Alternative mecha-
nisms of tolerance induction appear to be operative. Thus. a tolero-
genic effect of donor liver-derived soluble MHC class I Ags has 
been suggested (8). but hepatic allografts from class I-deficient 
donors are also accepted indefinitely (9). More recent observations 
have implicated donor leukocyte microchimerism (10-12) and. in 
particular. a role for donor-derived dendritic cell progenitors (13) 
in liver transplant tolerance. The precise mechanism(s) underlying 
this phenomenon. however. remains to be elucidated. 
Two recent studies in mice have focussed attention on the pos-
sibility that apoptotic death of graft-infiltrating cells mediated 
through activation of the Fas/Apo-l (CD95) receptor system might 
contribute to the immune privilege of tissues such as the testis (14) 
and the anterior chamber of the eye (15). Although apoptosis has 
been described as a mode of hepatocyte death in al.lograft rejection 
(16). and other liver diseases (17). little attention appears to have 
been paid to programmed cell death in the inflammatory cell in-
filtrate in liver transplantation. 
In the present study. we hypothesized that spontaneous mouse 
liver allograft acceptance might be due to a high level of in situ 
death of graft-infiltrating cells. in panicular CTL. while CTLp 
within recipient lymphoid tissue might persist. We first examined 
the kinetics of cytotoxic activity exhibited by freshly isolated liver 
allograft NPC. High antidonor CTL activity early (4 days) after 
transplantation was followed by a marked decline thereafter. Fol· 
lowing in vitro stimulation. however. high levels of CTL were still 
generated by both liver NPC and spleen cells. Evidence was then 
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obtained for the apoptosis of graft-infiltrating cells. associated with 
the progressive decline in expression of CTL function. Apoptotic 
activity was reduced. and CfL activity of freshly isolated cells was 
increased however. in NPC obtained from mice in which acute 
liver rejection was induced by the systemic injection of IL-2. a T 
cell growth factor known to inhibit programmed cell death of 
CTL (18). 
Materials and Methods 
Mice 
Male C57BUlOJ (BIO; H2b). C3H/HeJ (C3H;H2k). and BALB/c By] 
(H2d) mice were purchased from The Jackson Laboratory (Bar Harbor. 
ME). The animals were maintained in the specific pathogen-free facility of 
the University of Pittsburgh Medical Center (Pittsburgll. PAl. provided 
with Purina rodent chow (Ralston Purina. SI. Louis. MO) and tap water ad 
libitum. and used at 10 to 12 wk of age. 
Orthotopic liver transplantation 
The B 10 to C3H strain combination that permits spontaneous acceptance of 
liver allografts was used. Operations were performed from B 10 donors to 
C3H recipients under inhalation anesthesia, using methoxyflurane (Pitman-
Moore. Atlanta. GA). Livers were transplanted orthotopically. using the 
technique of Qian et al. as previously described (19). No hepatic artery 
revascularization was attempted. and no immunosuppressive therapy was 
used. Isografts (C3H-+C3H) were also performed for control purposes. 
Tissues were obtained from the animals on days 2. 4. 7. 14. 60, and 150 
after liver transplantation (day 0). There were at least three animals in each 
experimental group. 
Liver rejection model 
As a model of acute primary liver allograft rejection. recombinant mouse 
IL-2 (Cetus Co .. Emeryville, CA; 4 x \05 Ulday i.p.) was administered to 
graft recipients for 5 days, starting on the day of transplant. 
Isolation of liver NPC 
Livers were perfused in situ with collagenase solution and further digested 
in vitro. and the NPC were isolated by centrifugation. using self-generating 
Percoll solution (Sigma Chemical Co .• St. Louis. MO) as described pre-
viously in detail (20). 
Flow cytometric analysis of donor and recipient T cells 
Both normal liver NPC and those isolated from liver allografts were ana-
l yzed for the relative frequency of pan T cells and T cell subsets expressing 
donor (B 10) or recipient (C3H) MHC class I Ags. Two-color immunotlu-
orescence staming was performed by first incubating the cells (5 x 10'1 
tube) for 60 min at 4°C with 100 ILl of phycoerythrin-conjugated anti-CD3 
(hamster IgG) or anti-CD4 or anti-CDS (both rat IgG2a; all mAbs from 
PharMingen. San Diego. CAl. The cells were washed twice. then 100 ILl of 
biotin-conjugated mouse IgG2a anti-mouse H-2Kb (donor) or H-2Kk (re-
cipient) mAbs (PharMingen) was added. After 6O-min incubation at 4°C. 
the cells were washed and then further incubated for 30 min at 4°C with 
streptavidin-conjugated mc (Jackson ImmunoResearch Laboratories. 
Inc .• West Grove. PAl. After additional washes. the cells were resuspended 
in 1% paraformaldehyde and analyzed in a FACScan flow cytometer (Bec-
ton Dickinson Co .. Mountain View. CAl. Appropnate fluorochrome-con-
jugated. isotype-matched. irrelevant mAbs were used as appropriate 
negative controls. 
Cell-mediated Iymphocytotoxicity assay 
Freshly isolated liver NPC or spleen cells obtained from C3H recipients of 
B 10 livers were used as effectors. The EL4 (H2h) lymphoma cell line 
(TIB39; American Type Culture Collection. Rockville. MD) was used as a 
source of specific target cells. The P815 (H2d ) mouse mastocytoma cell 
line (TIB64. American Type Culture Collection) and the RI.I (HZk) mouse 
lymphoma cell line (TIB42; Amencan Type Culture Collection) were used 
as third party and syngeneic targets. respectively. The target cells were 
labeled with 100 ILCi of rjlCrlka~CrM4 (New England Nuclear. Boston. 
\.fA). washed. and plated at a concentration oi 5 x 10J cells/well in 96-well 
round-bollom culture plates (Coming. Coming. NY). Serial. twolold dilu-
tIons 01 etfector cells were added to give E:T ratios 01 100: I. 50: I. and 25: 1 
In a total \lolume at 200 ILUwe11. The percentage ot specltic 'ICr release 
was determtned after incubating the plates lor 4 h at J7"C in 5% Cl~ in air. 
An alIquot (100 ILl) of supernatant was recovered from each well after 
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centrifugation at 500 X g for 1 min. Maximum 51Cr release was deter-
mined by osmotic lysis of the cells. The percent specific cytotoxicity was 
calculated using the following formula: % cytotoxicity = 100 X [(exper-
imental cpm - spontaneous cpm)/(maximum cpm - spontaneous cpm)]. 
The results are expressed as the mean:: I SO of tile percent specific StCr 
release in triplicate cultures. For the in vitro generation of CTL. 2 X 106 
C3H splenic or liver T cells from normal mice or B 10 allograft recipients 
were cultured with irradiated syngeneic (C3H) or allogeneic (B 10) stimu-
lator spleen cells at a low stimulator:responder ratio (1:4) for 96 h in 24-
well plates. The stimulated T cells were then harvested. dead cells were 
removed by Ficoll purification. and CTL activity was determined as 
described above. 
In situ detection of apoptotic cells in tissue sections 
Liver grafts were harvested. and diced tissue samples were placed in em-
bedding medium <Tissue-Tek ocr Compound. Miles, Inc .• Elkhart. IN). 
The tissue was snap-frozen in liquid nitrogen and stored at - 80°C until 
sectioned. Cryosections were cut at 4 /Lm, mounted on precleaned slides. 
air-dried overnight at room temperature. then fixed for 10 min at room 
temperature in 10% neutral buffered formaldehyde (pH 7.4). followed by 
two washes (5 min each) in PBS. DNA strand breaks were identified by in 
situ terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end-
labeling (TUNEL) (21). Sections were immersed in 2% H20 2 in PBS for 
5 min at room temperature to quench endogenous peroxidase activity. tllen 
incubated with 20 iLglml proteinase K (Sigma Chemical Co.) for 15 min at 
room temperature. washed in PBS. and immersed in reaction buffer sup-
plemented with terminal deoxynucleotidyl transferase and biotinylated 
dUTP. Sections were incubated in a humid atmosphere at 37"C for 60 min. 
Each experiment was performed with a negative control (without biotin-
ylated dUTP) and a positive control (1 O-min pretreatment of sections with 
1 mglml DNase dissolved in reaction buffer). Irradiated (500 rad) thymo-
cytes incubated for 18 h. then cytocentrifuged onto glass slides (>90% 
apoptotic cells). also served as positive controls. After washing in stopl 
wash buffer (30 min at 37"C). anti-digoxigenin peroxidase (Oncor, Gaith-
ersburg. MD) was added (30 min at room temperature). The sections were 
washed in PBS. and tile reaction was developed with 3-amino-5-ethycar-
bizot. Slides were counterstained with Harris' hematoxylin and mounted 
with Crystal mount (Biomeda Corp .• Foster City. CAl. The average num-
ber of labeled cells per higll power tield was determined. and the results are 
expressed as the mean:: I SO. 
DNA fragmentation a5say 
The protocol used was a modification of that described previously (22, 23). 
NPC (5 X lOb) isolated from the grafted livers were cultured in RPMII640 
(Life Technologies. Grand Island. NY) for 18 h in 24-well plates. The cells 
were washed three times in PBS and transferred to I-ml microcentrifuge 
tubes. After centrifugation. the supernatant was removed. and tile cells 
were lysed by incubation in 400 ILl uf buffer containing 5 mM Tris. pH 8.0: 
I mM EDTA; and 0.5% Triton X-loo at 4°C for 30 min. The lysates were 
then spun at 16.250 x I? for 30 min. and the supernatants were transferred 
to separate tubes. A second aliquot of lysis buffer was laid gently onto the 
pellet. and the tubes were spun again. The supernatant from each tube was 
removed and added to tile previous supernatant. Each pellet was then re-
suspended in a volume of lysis buffer equal to the total supernatant volume. 
The supernatant and pellet fractions were sOnicated. and the samples were 
plated in triplicate 100-1L1 serial dilutions in Dynatech Microfluor 96-well 
plates (Dynatech Laboratones. Inc .• Chantilly. VA). Then. 100 ILiaI' a 
solution containing 0.6 ILglml of the fluorescent DNA tag DAP! (4.6-dia-
midino-2-pllenylindole: Sigma Chemical Co.) in a buffer containing \0 
mM Tris. pH 8.0. and 100 mM NaCI was added to each sample. The 
amount of DNA was calculated from the emission at 465 nm. measured on 
a Dynatech Microfluor plate reader (350 nm excitation). After mathemat-
ical converston of the data. fragmentation was calculated as: % DNA frag-
mentation = 100 x !DNA in supernatant/DNA in supernatant + pellet). 
Results 
Quantitation of donor and recipient T cells within liver 
Jllografts 
Groups of unmodified C3H recipients of B 10 livers were killed 2. 
~K 7. 14, and 150 days after transplantation. The incidence of T 
cells and both CD4 ~ and CD8 + subsets within the freshly isolated 
\lPC populations that were either donor or recipient denved was 
quantitated by two-color flow cytometric analysis. As shown to 
Figure 1. the liver transplants were mfiltrated rapidly (wuhm 2 
days) by reCipient MHC class I ~ (H2Kk +) T cells. By day 4. 95% 
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FIGURE 1. Flow cytometric analysis (MHC class I staining) of donor 
(H2Kb +) and recipient (H2Kk +) T cells and subsets in freshly isolated 
NPC populations from liver allografts (Bl0-C3H) at various times 
after transplantation. The results are representative of three separate 
experiments. 
of the CD3 + cells within the liver were of recipient origin. Of 
these, approximately two-thirds were CD4+ cells. CD8+ cells 
however, represented a higher proportion of the T cell infiltrate on 
days 7 and 14. By day 150, the number of (recipient) T cells within 
liver allografts was similar to that in normal liver. 
Kinetics of cytotoxic activity of liver NPC and spleen cells of 
liver graft recipients 
We next analyzed the CTL activity of graft-infiltrating cells iso-
lated from mice killed 4,7, 14, and ISO days after transplantation. 
By day 4, freshly isolated liver allograft NPC showed substantial 
levels ofCTL activity (>40% specific 'ICr release at a 100:1 E:T 
ratio) against target cells expressing donor alloantigens (EL4; 
H2b), but not toward third-party (P8I5: H2d ) or syngeneic (Rl.1: 
Ht') targets (Fig. 2A). After day 4, CfL activity declined to 37% 
(day 7), 12% (day 14), and subsequently to normal control values 
(by day ISO; Fig. 2A). Compared with NPC, freshly isolated re-
cipient spleen cells (Fig. 2B) showed much lower levels of cyto-
lytic activity against donor targets (12% specific lysis at a 100: I 
E:T ratio) on day 4. There was a decline to 7% on day 7, and 
normal control values were reached by day 14. These results in-
dicated that donor-specific. cell-mediated immunity. manifested by 
massive lymphocytic infiltration and high levels of donor-specific 
en. within the graft, was induced within a few days of liver trans-
plantation. It was also clear, however, that by day 14, the in situ 
donor-specific immune response had subsided due to a marked 
reduction in CTL activity within the graft. In Iiver-allografted mice 
in which acute graft rejection was induced by the systemic admin-
istration of mouse rIL-2, there was a significant increase in the 
CTL activity of freshly isolated NPC determined 4 days post-trans-
plant (Table I). 
Generation of CTL from the spleens of liver allograft 
recipients 
We then investigated the in vitro generation of CTL from the 
spleens of liver allograft recipients harvested 4, 7, 14, and 150 days 
after transplantation. Normal C3H or graft recipient spleen cells 
were cultured with 'Y-irradiated B 10 splenocytes at a low stimula-
tor:responder ratio for 4 days. The cytotoxic activity of the stim-
ulated C3H cells was then determined against donor-specific, 
tltird,-party, and syngeneic targets. Compared with normal spleen 
cells that gave 7.2 ± 0.8% donor-specific cell killing (E:T ratio = 
100:1), elevated levels of CTL activity were observed at all time 
points, with a peak of specific SICr release (69.8 ± 3.4% at an E:T 
ratio.of 100:1) 4 days post-transplant (Fig. 3). CTL exhibiting 
between 43 and 54% specific target cell lysis were generated from 
spleen cells obtained 7 to 14 days post-transplant. Thus, apprecia-
ble levels of donor-specific en. could still be generated from host 
lymphoid tissue at least 14 days after transplantation despite liver 
allograft acceptance. Even by day ISO, it was still possible-to gen-
erate low, but significant, donor-specific CTL activity above that in 
normal spleen cells (15.4 ± 1.2% specific donor cell lysis). Similar 
results were obtained for the in vitro generation of CTL from liver 
NPC of liver allograft recipients (data not shown). 
In situ visualization of programmed cell death 
We speculated that the diminution in CTL function of the freshly 
isolated liver graft-infiltrating cells might be due to a high inci-
dence of in situ apoptotic death of activated T cells. The fate of 
infiltrating mononuclear cells within the graft was therefore eval-
uated by investigation of their in situ apoptotic activity using the 
TUNEL assay. Compared with liver isografts (C3H-C3H), 
which showed only a modest inflammatory cell infiltrate on days 4, 
7, and 14. there was heavy mononuclear cell infiltration of the 
BlO-C3H liver allografts. Despite the significant ex vivo donor-
specUic CfL activity, these graft-infiltrating cells appeared innoc-
uous in vivo, as there was little morphologic evidence of hepato-
cellular necrosis. Nick end-labeled apoptotic cells within the 
infiltrates were readily evident by day 4 after transplant (Fig. 4B) 
and increased in number by day 7 (Figs. 4C and 5). Thereafter, 
TUNEL-positive cells became progressively less numerous, al-
though small numbers were evident 60 days post-transplant. In 
comparison. the number of positively staining (apoptotic) paren-
chymal cells was lower at all points tested. On day 7, it represented 
less than one-third of that in the TUNEL positive inflammatory 
cells. In liver isografts, the incidences of both apoptotic parenchy-
mal cells and NPC were consistently very low (Figs. 4A and 5). 
The next question addressed was whether apoptosis of graft-
infiltrating cells represented a primary mechanism by which livers 
were accepted spontaneously or constituted an epiphenomenon of 
the alloimmune response. To further determine the relationship 
between apoptotic NPC and liver graft acceptance, the incidence of 
apoptotic graft-infiltrating cells in nonrejecting allogeneic livers 
was compared with that in rejecting hepatic allografts. Acute liver 
rejection was induced by the systemic administration of mouse 
rIL-2. As shown in Figure 5. IL-2 treatment (which resulted in 
enhanced specific en. activity within the graft) was accompanied 
by a lower incidence (compared with that in tolerant animals at the 
i 
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FIGURE 2. Cytotoxic activity of freshly isolated 
liver NPC (A) and spleen cells (8) from C3H re-
cipients of BID hepatic allografts. A 4-h SlCr re-
lease assay was used to determine cytotoxicity 
against target cells expressing donor (H2b) alloan-
tigen 4, 7, 14, and 150 days after transplantation. 
Third-party (H2d ) and syngeneic (H2k) target cells 
were also used. Cells were pooled from groups of 
three transplanted animals, and the experiment 
was performed three times. 
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Table I. Influence of systemic /L-2 on the cytotoxic activity of freshly-isolated NPC from C3H (Hi'J recipients of 810 (H2bJ liver allografts d 
Targets: % Specific SlCr Releaseb 
EL4 (H2h) (allogeneic) P81S (H2d ) (third party) R1.1 (H2k) (syngeneic) 
Treatment 100:1' 50:1 25:1 100:1 50:1 
None 43.1 :!: 1.9 
64.5 :!: 2.7" 
33.8:!: 1.6 
46.9:!: 1.7d 
31.5:!: 2.9 
36.0:!: 1.3d 
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FIGURE 3. Generation of CTl from the spleens 
of C3H (H2kl mice that received an orthotopic 
BID (H2b) liver transplant 4.7. 14. or 150 days 
previously. Splenic T cells were incubated for 
96 h with 'Y-irradiated (20 Gy) 810 spleen cell 
stimulators at a low stimulator:responder ratio (1 :4) 
then used as electors. The elector cells were cui· 
tured with target cells expressing the haplotype of 
donor (El4; Hi'; 0) or with third-party (PSIS; H2d; 
L:l.l or syngeneic (R 1.1; H2k; .l targets. Cells were 
pooled from groups of three transplanted animals. 
and the experiment was performed four times. Re-
sults are the mean:!: 1 SO. 
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FIGURE 4. Apoptotic cells identified in portal areas of liver grafts by TUNEL staining. as described in Materials and Methods. A. Isograit 
(C3H ...... C3H), day 7; 8, allograft (81 O ...... C3H), day 4; C. allograft. day 7; D, allograft plus IL·2 administration. day 4. The cells were counterstained 
with hematoxylin. Magnification: A. B. and D, X400; C. X200. 
same point (day 4)) of apoptotic cells within the inflammatory 
infiltrate (see also Fig. 4D); by contrast. there was a significant 
increase in hepatocyte death (TUNEL-positive cells) with IL-2 
treatment (Fig. 5). These tindings suggest that liver allograft sur· 
vival may be the result of a relatively high level of apoptosis 
within the graft-intiltrating cell population that subvens the elt"ec-
tor arm of the host immune response. 
DNA fragmentation in cultured graft-infiltrating cells 
Apoptosis was quantitated in NPC isolated from liver grafts 
(isografts. allografts. and allografts with IL-2 treatment) 4. 7, and 
14 days after transplant (Fig. 6). The cells were cultured overnight 
(18 h) without stimulation. DNA fragmentation. an indicator of 
apoplOtic cell death. was then quantitated. Cells from accepted 
allografts showed much higher DNA fragmentation on day 4 
----~---------"- '-'--' 
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FIGURE 5. Incidence of apoptotic cells determined, as described in 
Materials and Methods, by in situ nick end labeling (TUNEU within the 
NPe (infiltratel and parenchymal cell populations of hepatic trans-
plants (isografts, allografts, and allografts plus Il-21 at various times 
after transplantation. 
(34.8:t 10.2%), day 7 (40.1 :t 1.2%). and day 14 (25.7 :t: 1.9%) 
compared with cells from isografts (12.6 :t 2.6%. 14.5 :t 5.7%. 
and 17.5 :t 2.4%. respectively: all {J < n.DI). Interestingly, NPC 
from rejecting allografts OL-2 treatment) exhibited significantly 
lower DNA fragmentation 0.2 :t 2.3% on day 4 post-transplan-
tation: {J < n.DI compared with isografts: Fig. 6) than those from 
tolerant or isografted mice. These data indicate that acute liver 
allograft rejection (induced by exogenous administration of mouse 
rIL-2) is associated with inhibition of graft-infiltrating cell 
apoptosis. 
Discussion 
Liver transplantation in mice across MHC and non-MHC histo-
compatibility barriers results in spontaneous graft acceptance and 
the induction of donor-specific tolerance. Paradoxically. however. 
vigorous MLR and CTL responses are generated ex vivo against 
donor alloantigens by liver graft-infiltrating cells and spleen cells. 
This phenomenon has been described as split tolerance 12). Similar 
findings have been reponed in rat liver transplantation models (4. 
24). The mechanisms underlying this in vivo/ex vivo functional 
disparity have been investigated extensively. but are still poorly 
understood. All allotransplanted livers initially undergo a brisk 
.:pisode of histologic rejection. This is manifested by heavy graft 
infiltration. but there is little hepalOcyte necrosis. The intlamma-
tory response decreases spontaneously within a few weeks (2. 25l. 
In this study. we speculated that programmed cell death of liver-
infiltrating cells might underlie functional tolerance. E.xamlna!ion 
llf donor-specific cytotoxic activity of graft-infiltrating cells re-
vealed high early (days 4-7) but rapidly diminishing eTL function 
against donor. This indicated that donor-specific immunity was 
induced initially. consistent with the massive lymphocytic infiltrate 
and the coincident high donor-specilic CTL activity observed 
,honly alter liver transplantation. It appears from our analvsls 01 
apoplllllc cell death that the rapid wanmg 01 the in SHU Immune 
response may be due III the elimmation 01 donor-specific eTL 
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within the graft. Formal proof of this hypothesis. however. requires 
the demonstration of selective deletion of graft-infiltrating CTL 
expressing TCR specific for donor MHC in mice bearing a high 
frequency of these cells. Thus. Bertolino et al. (26) have recently 
described the peripheral deletion of autoreactive CD8+ T cells in 
transgenic mice expressing allogeneic MHC class I in the liver. 
Notably, in experimental models of autoimmune disease. there is 
evidence of apoptotic elimination of target Ag-specific T lympho-
cytes within the affected organ. Moreover. it has been suggested 
that this mechanism may contribute to the subsidence of inflam-
mation and the development of tolerance (27, 28). 
In vitro studies have demonstrated that triggering of primary 
activated T cells via the TCR may lead to their death by apoptosis. 
but that resting T cells. such as CTLp, are not susceptible (29-32). 
We hypothesized that apoptosis of CTL within the liver might 
provide a mechanistic basis of allograft acceptance. Host recogni-
tion of donor alloantigens induces activation and subsequent pro-
liferation of T lymphocytes bearing Ag-specific receptors. In the 
case of mouse heart and skin grafts. this results invariably in CTL-
mediated graft rejection. With liver grafts. however. the initial ex-
tensive expansion of Ag-reactive T cell clones and graft infiltration 
is followed by attenuation of the CTL effector response. Rather 
than being rejected. the graft survives. 
Clonal down-regulation during immune responses is a poorly 
characterized phenomenon. It seems likely, however, that some 
form of activation-induced cell death is involved. In vitro'studies 
suggest that the susceptibility of activated CTL to apoptosis may 
relate to the interaction of CD95 ligand with its cell death-trans-
ducing receptor CD95 (Fas! Apo-I) (32). CTLp that lack CD95 
(33), however. are less sensitive to apoptosis. As apparent from the 
tindings of the present study. CTLp present in spleen may continue 
to provide the basis for renewal of the potential effector CTL pop-
ulation after liver transplantation. There are recent repons of high 
levels of expression of CD95L on parenchymal cells within im-
munologically privileged siles (34), in panicular the mouse testis 
( 14) and the anterior chamber of the eye ( 15). This has been linked 
to the death of specific activated T cells and to the maintenance of 
immune privilege within these sites. Others. however. have chal-
lenged the interpretation of these findings on the basis that no data 
for T cell functions were reported (35). Normal rodent and human 
livers do not appear to express CD95L mRNA (34. 36. 37), but 
CD95L mRNA is found within hepatocytes in inflammatory liver 
disease (36). Thus. CD95-CD95L interactions may provide a 
mechanism underlying apoptosis of liver allograft-infiltrating T 
cells. Even though CD95!CD95L interactions may not be essential 
mediators of T cell-induced allograft damage (38). they may play 
a regulatory role in both the clonal expression and the subsequent 
contraction of the T cell response. Others. however. have shown 
similar CD95L transcripts in mouse heart allograft rejection and 
tolerance models (39). Interactions between other cell surface-ex-
pressed receptor-ligand pairs (e.g .• intracellular adhesion mole-
cule-IILFA-1. and 4-IBB!4-IBBL (40) and the roles of other 
members of the TNF family. including TNF. CD30 ligand. and 
CD40 ligand) that may enhance or inhibit CD95-mediated activa-
tion-induced cell death are also currently being tested. In addition. 
specific cytokines produced by liver cells. in panicular TGF-.B 
(of I). which can induce T cell apoptosis (42), may be involved. One 
possibility. hased on other models 01 alloreactivity. is that delellon 
()f high affinity T cells may occur in vivo as a result of exhaustive 
dilferentiation (7. :26) in the presence of large amounts of donor Ag 
III the liver. The surVival of low affinity cells (that function poorly 
III vivo. may provide a basis lor the strong In Vitro response to 
alloanugens. 
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from liver allografts 4, 7, and 14 days after trans-
plantation. The cells were cultured overnight (18 h) 
without stimulation. DNA fragmentation was then 
measured as described in Materials and Methods. 
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Taken together, our observations suggest that a mechanism un-
derlying the acceptance of MHC-disparate liver allografts in non-
immunosuppressed mice may be the apoptotic death of alloreac-
tive CTL that occurs predominantly within the graft and is 
triggered by donor alloantigens. The death of donor-reactive T 
cells may also be attributable at least in part to interaction with 
donor liver-derived leukocytes, in particular populations of poten-
tial migratory dendritic cells (20, 43) that may express CD95L and 
have the ability to trigger apoptosis in activated allogeneic T cells -
(44, 45). Conceivably, apoptosis mediated by factors including 
specific cytokines or nitric oxide (46,47) may also occur in donor 
leukocytes (dendritic cells and macrophages) present within the 
graft NPC population. This, too, could contribute to the regulation! 
subversion of what is, essentially, a two-way alloimmune 
response. 
TCR triggering of activated T cells may lead to their death by 
apoptosis unless the T cells are rescued by growth-promoting sig-
nals such as IL-2 and IL-4 (18, 48, 49). The implication of the 
present findings is that IL-2, either alone or together with addi-
tional signals, may protect the CfL from apoptosis, thus predis-
posing to liver graft rejection. 
Liver transplant tolerance is evident in all MHC-disparate 
mouse strain combinations that have been tested (1). Moreover, 
Ags introduced into the liver (via the portal venous or oral route) 
can induce Ag-specific tolerance (50). Several distinctive features 
of the liver microenvironment may contribute to its immunologic 
privilege and its inherent tolerogenicity. These include its regen-
erative capacity and a comparatively heavy endowment of ("pas-
senger") leukocytes (51), including stem cells (52, 53), compared 
with that of kidney or heart. In rodent liver transplant models, 
these cells and their cytokine products may be essential for graft 
survival (11, 12) and may include donor-derived tolerogenic or 
deletional APe (13), such as may be represented by costimulatory 
molecule-deficient dendritic cell progenitors derived from the liver 
(13.54). Further investigation of the role of programmed cell death 
in regulating immune responses within liver and other organ allo-
grafts (including challenge grafts that are tolerated in liver recip-
ients) may provide new insight into their comparative immune 
privilege and tolerogenicity. 
We have shown for the first time that high relative levels of T 
lymphocyte apoptosis within the graft-infiltrating cell population 
are correlated with liver allograft survival in nonimmunosup-
pressed recipients. Although this finding sheds light on why livers 
may be accepted in the face of ex vivo alloimmune reactivity, the 
mechanism of systemic tolerance induced by liver transplantation 
remains LO be elucidated. As shown previously, however. in both 
mouse and rat models. systemic effects of liver transplantation in-
clude the capacity of liver leukocytes (including progenitor and 
5 10 15 
Days after Transplantation 
stem cells) (12) to migrate extensively to recipient lymphoid tis-
sues, where they may persist indefinitely (1, 51). These chimeric 
cells may provide not only a continuing source of allostimulation, 
but may also have the capacity to modulate the survival and func-
tion of alloactivated T cells within the recipient lymphoid 
system (55). 
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